CARBOGEN AMCIS AG

CARBOGEN AMCIS AG is a Switzerland-based contract development and manufacturing organization (CDMO) that provides end‑to‑end services for the development and commercial supply of active pharmaceutical ingredients (APIs) and drug products. Part of the Dishman Carbogen Amcis group, the company supports pharmaceutical and biotechnology customers from early process design through clinical supply and commercial manufacturing.

Its capabilities include route scouting, process R&D, custom synthesis, scale‑up, and GMP manufacturing of complex small molecules, including highly potent APIs (HPAPIs) and cytotoxic compounds. The company also offers development and manufacturing of antibody–drug conjugate (ADC) payloads and linkers, as well as sterile parenteral drug product development and aseptic fill‑finish. Comprehensive analytical services—method development, validation, stability studies, and quality control—are integrated with regulatory and technology transfer support. Operations span a network of specialized facilities in Europe, with containment infrastructure designed for safe handling of high‑hazard substances and compliance with international GMP standards.